199 related articles for article (PubMed ID: 20949774)
1. Treatment of malignant pleural mesothelioma: current status and future directions.
Dhalluin X; Scherpereel A
Monaldi Arch Chest Dis; 2010 Jun; 73(2):79-85. PubMed ID: 20949774
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy and radiotherapy for mesothelioma.
Dhalluin X; Scherpereel A
Recent Results Cancer Res; 2011; 189():127-47. PubMed ID: 21479899
[TBL] [Abstract][Full Text] [Related]
3. Guidelines of the French Speaking Society for Chest Medicine for management of malignant pleural mesothelioma.
Scherpereel A;
Respir Med; 2007 Jun; 101(6):1265-76. PubMed ID: 17137779
[TBL] [Abstract][Full Text] [Related]
4. Current concepts in malignant pleural mesothelioma.
Kaufman AJ; Pass HI
Expert Rev Anticancer Ther; 2008 Feb; 8(2):293-303. PubMed ID: 18279069
[TBL] [Abstract][Full Text] [Related]
5. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma.
Scherpereel A; Astoul P; Baas P; Berghmans T; Clayson H; de Vuyst P; Dienemann H; Galateau-Salle F; Hennequin C; Hillerdal G; Le Péchoux C; Mutti L; Pairon JC; Stahel R; van Houtte P; van Meerbeeck J; Waller D; Weder W;
Eur Respir J; 2010 Mar; 35(3):479-95. PubMed ID: 19717482
[TBL] [Abstract][Full Text] [Related]
6. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.
Scherpereel A; Opitz I; Berghmans T; Psallidas I; Glatzer M; Rigau D; Astoul P; Bölükbas S; Boyd J; Coolen J; De Bondt C; De Ruysscher D; Durieux V; Faivre-Finn C; Fennell D; Galateau-Salle F; Greillier L; Hoda MA; Klepetko W; Lacourt A; McElnay P; Maskell NA; Mutti L; Pairon JC; Van Schil P; van Meerbeeck JP; Waller D; Weder W; Cardillo G; Putora PM
Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32451346
[TBL] [Abstract][Full Text] [Related]
7. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.
Opitz I; Scherpereel A; Berghmans T; Psallidas I; Glatzer M; Rigau D; Astoul P; Bölükbas S; Boyd J; Coolen J; De Bondt C; De Ruysscher D; Durieux V; Faivre-Finn C; Fennell DA; Galateau-Salle F; Greillier L; Hoda MA; Klepetko W; Lacourt A; McElnay P; Maskell NA; Mutti L; Pairon JC; Van Schil P; van Meerbeeck JP; Waller D; Weder W; Putora PM; Cardillo G
Eur J Cardiothorac Surg; 2020 Jul; 58(1):1-24. PubMed ID: 32448904
[TBL] [Abstract][Full Text] [Related]
8. [Malignant mesothelioma].
Scherpereel A
Rev Prat; 2009 Jun; 59(6):751-5. PubMed ID: 19642427
[TBL] [Abstract][Full Text] [Related]
9. Future developments in the management of malignant pleural mesothelioma.
Zucali PA; De Vincenzo F; Simonelli M; Santoro A
Expert Rev Anticancer Ther; 2009 Apr; 9(4):453-67. PubMed ID: 19374599
[TBL] [Abstract][Full Text] [Related]
10. [Malignant pleural mesothelioma: diagnosis and treatment].
Delourme J; Dhalluin X; Cortot AB; Lafitte JJ; Scherpereel A
Rev Pneumol Clin; 2013 Feb; 69(1):26-35. PubMed ID: 23333048
[TBL] [Abstract][Full Text] [Related]
11. [Malignant pleural mesothelioma: early diagnosis and multimodality management].
Pavia R; Mondello B; Barone M; Surleti S; Puliafito M; Barresi P
G Chir; 2005; 26(6-7):257-60. PubMed ID: 16332304
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of malignant pleural mesothelioma--present status and future view].
Yano T; Morodomi Y; Ito K; Miura N; Takenaka T; Kawano D; Shoji F; Maehara Y
Fukuoka Igaku Zasshi; 2008 Apr; 99(4):74-9. PubMed ID: 18646592
[No Abstract] [Full Text] [Related]
13. European guidelines for the management of malignant pleural mesothelioma.
van Thiel E; van Meerbeeck JP
Pol Arch Med Wewn; 2010 Dec; 120(12):503-10. PubMed ID: 21178907
[TBL] [Abstract][Full Text] [Related]
14. Targeted therapies in malignant pleural mesothelioma: a review of clinical studies.
Greillier L; Marco S; Barlesi F
Anticancer Drugs; 2011 Mar; 22(3):199-205. PubMed ID: 21263312
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic strategies for resectable malignant pleural mesothelioma].
Hasegawa S
Nihon Geka Gakkai Zasshi; 2009 Nov; 110(6):338-42. PubMed ID: 19999568
[TBL] [Abstract][Full Text] [Related]
16. Kinesin family members KIF11 and KIF23 as potential therapeutic targets in malignant pleural mesothelioma.
Kato T; Lee D; Wu L; Patel P; Young AJ; Wada H; Hu HP; Ujiie H; Kaji M; Kano S; Matsuge S; Domen H; Kaga K; Matsui Y; Kanno H; Hatanaka Y; Hatanaka KC; Matsuno Y; de Perrot M; Yasufuku K
Int J Oncol; 2016 Aug; 49(2):448-56. PubMed ID: 27279560
[TBL] [Abstract][Full Text] [Related]
17. Advances in treatment of mesothelioma.
Maggioni C; Barletta G; Rijavec E; Biello F; Gualco E; Grossi F
Expert Opin Pharmacother; 2016 Jun; 17(9):1197-205. PubMed ID: 27055148
[TBL] [Abstract][Full Text] [Related]
18. Biology and management of malignant pleural mesothelioma.
Zucali PA; Giaccone G
Eur J Cancer; 2006 Nov; 42(16):2706-14. PubMed ID: 16989994
[TBL] [Abstract][Full Text] [Related]
19. From the archives of the AFIP. Malignant pleural mesothelioma: radiologic-pathologic correlation.
Miller BH; Rosado-de-Christenson ML; Mason AC; Fleming MV; White CC; Krasna MJ
Radiographics; 1996 May; 16(3):613-44. PubMed ID: 8897628
[TBL] [Abstract][Full Text] [Related]
20. A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy.
Watanabe Y; Kojima T; Kagawa S; Uno F; Hashimoto Y; Kyo S; Mizuguchi H; Tanaka N; Kawamura H; Ichimaru D; Urata Y; Fujiwara T
Oncogene; 2010 Feb; 29(8):1145-54. PubMed ID: 19935710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
